Did not achieve enrollment goal

The Livongo-Insulia Study App Pilot Study (LISA Pilot) is a 3-month, prospective, interventional study. The purpose of this pilot study is to evaluate the feasibility of using the Livongo-Insulia Study App for individuals with type 2 diabetes using basal insulin. This will be assessed by measuring the impact of the Livongo-Insulia Study App on glycemic control for these individuals.

Inclusion Criteria:

• Age ≥ 18 years
• Lives in the U.S.
• Able to speak, read and write in English
• Diagnosed with type 2 diabetes
• Currently treated with long-acting basal insulin analog (Lantus, Levemir, Toujeo, Basaglar, Tresiba U-100) and taking 1 injection per day
• Takes a daily dose ≤ 0.75 units/kg
• Estimated A1c ≥ 8% (based on existing Livongo data)
• Has been enrolled in Livongo for at least 12 weeks
• Uses an iPhone compatible with Insulia's compatibility matrix (iPhone 5 or higher; iOS 8 or newer)
• Willing to complete study questionnaires
• Willing to complete at-home A1c kits
• Willing to check before breakfast blood glucose at least once per day

Exclusion Criteria:

• Diagnosis of type 1 diabetes
• Currently using a long-acting basal insulin analog that is not supported by Insulia
• Currently using rapid-acting, short-acting, or intermediate-acting or premixed insulins
• Currently pregnant or planning pregnancy